These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 32821492

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging.
    Göbel AP, Fleckenstein M, Heeren TF, Holz FG, Schmitz-Valckenberg S.
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):59-67. PubMed ID: 25904296
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy.
    Sauer L, Peters S, Schmidt J, Schweitzer D, Klemm M, Ramm L, Augsten R, Hammer M.
    Acta Ophthalmol; 2017 Aug; 95(5):481-492. PubMed ID: 27775222
    [Abstract] [Full Text] [Related]

  • 28. Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration.
    Dysli C, Wolf S, Zinkernagel MS.
    Invest Ophthalmol Vis Sci; 2016 May 01; 57(6):2479-87. PubMed ID: 27149697
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Quantitative Fundus Autofluorescence in Early and Intermediate Age-Related Macular Degeneration.
    Gliem M, Müller PL, Finger RP, McGuinness MB, Holz FG, Charbel Issa P.
    JAMA Ophthalmol; 2016 Jul 01; 134(7):817-24. PubMed ID: 27253610
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression.
    Dysli C, Wolf S, Hatz K, Zinkernagel MS.
    Invest Ophthalmol Vis Sci; 2016 Mar 01; 57(3):832-41. PubMed ID: 26934141
    [Abstract] [Full Text] [Related]

  • 38. Correlation of Color Fundus Photograph Grading with Risks of Early Age-related Macular Degeneration by using Automated OCT-derived Drusen Measurements.
    Cheung CMG, Shi Y, Tham YC, Sabanayagam C, Neelam K, Wang JJ, Mitchell P, Cheng CY, Wong TY, Cheung CYL.
    Sci Rep; 2018 Aug 28; 8(1):12937. PubMed ID: 30154521
    [Abstract] [Full Text] [Related]

  • 39. Repeatability of Fluorescence Lifetime Imaging Ophthalmoscopy in Normal Subjects With Mydriasis.
    Kwon S, Borrelli E, Fan W, Ebraheem A, Marion KM, Sadda SR.
    Transl Vis Sci Technol; 2019 May 28; 8(3):15. PubMed ID: 31114715
    [Abstract] [Full Text] [Related]

  • 40. Effect of pharmacologically induced retinal degeneration on retinal autofluorescence lifetimes in mice.
    Dysli C, Dysli M, Zinkernagel MS, Enzmann V.
    Exp Eye Res; 2016 Dec 28; 153():178-185. PubMed ID: 27777124
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.